JP2021091671A5 - - Google Patents

Download PDF

Info

Publication number
JP2021091671A5
JP2021091671A5 JP2020196447A JP2020196447A JP2021091671A5 JP 2021091671 A5 JP2021091671 A5 JP 2021091671A5 JP 2020196447 A JP2020196447 A JP 2020196447A JP 2020196447 A JP2020196447 A JP 2020196447A JP 2021091671 A5 JP2021091671 A5 JP 2021091671A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
alkyl
ring
aromatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2020196447A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021091671A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2021091671A publication Critical patent/JP2021091671A/ja
Publication of JP2021091671A5 publication Critical patent/JP2021091671A5/ja
Ceased legal-status Critical Current

Links

JP2020196447A 2019-11-28 2020-11-27 多環性ピリドン誘導体を含有する医薬組成物 Ceased JP2021091671A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019214867 2019-11-28
JP2019214867 2019-11-28

Publications (2)

Publication Number Publication Date
JP2021091671A JP2021091671A (ja) 2021-06-17
JP2021091671A5 true JP2021091671A5 (https=) 2023-11-29

Family

ID=76312248

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020196447A Ceased JP2021091671A (ja) 2019-11-28 2020-11-27 多環性ピリドン誘導体を含有する医薬組成物

Country Status (1)

Country Link
JP (1) JP2021091671A (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021107065A1 (ja) 2019-11-28 2021-06-03 塩野義製薬株式会社 多環性ピリドピラジン誘導体
EP4066839A4 (en) 2019-11-28 2023-12-27 Shionogi & Co., Ltd PROPHYLACTIC AND THERAPEUTIC MEDICINAL PRODUCT FOR HIV INFECTIOUS DISEASES, CHARACTERIZED BY CONTAINING THE COMBINATION OF INTEGRAS INHIBITORS AND ANTI-HIV AGENTS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9216995B2 (en) * 2010-04-12 2015-12-22 Shionogi & Co., Ltd. Pyridone derivative having integrase inhibitory activity
JPWO2016027879A1 (ja) * 2014-08-22 2017-06-01 塩野義製薬株式会社 インテグラーゼ阻害活性を有する多環性ピリドン誘導体
US10624912B2 (en) * 2015-11-17 2020-04-21 Merck Sharp & Dohme Corp. Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors
US10548910B2 (en) * 2015-11-17 2020-02-04 Merck Sharp & Dohme Corp. Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors
EP3752144B1 (en) * 2018-02-15 2022-12-28 Merck Sharp & Dohme LLC Tricyclic heterocycle compounds useful as hiv integrase inhibitors
MA52802A (fr) * 2018-05-31 2021-04-14 Shionogi & Co Dérivé de pyridone polycyclique

Similar Documents

Publication Publication Date Title
JPWO2019230857A5 (https=)
JPWO2019230858A5 (https=)
JP2021091671A5 (https=)
US8299265B2 (en) Amine derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
Barreca et al. Discovery of 2, 3-diaryl-1, 3-thiazolidin-4-ones as potent anti-HIV-1 agents
US9150507B2 (en) Amine derivative having NPY Y5 receptor antagonistic activity
Huang et al. Synthetic routes and structure-activity relationships (SAR) of anti-HIV agents: A key review
US20030134888A1 (en) Pyrazole derived kinase inhibitor
Hadda et al. Tautomeric origin of dual effects of N 1-nicotinoyl-3-(4′-hydroxy-3′-methyl phenyl)-5-[(sub) phenyl]-2-pyrazolines on bacterial and viral strains: POM analyses as new efficient bioinformatics’ platform to predict and optimize bioactivity of drugs
Cikotiene et al. 5-Aryl-4-(5-substituted-2, 4-dihydroxyphenyl)-1, 2, 3-thiadiazoles as inhibitors of Hsp90 chaperone
Song et al. Diversity-oriented synthesis and antifungal activities of novel pimprinine derivative bearing a 1, 3, 4-oxadiazole-5-thioether moiety
Hameed et al. Schiff bases and Bicyclic derivatives comprising 1, 3, 4-thiadiazole moiety-A Review on their Pharmacological activities
Thanh et al. Thiourea derivatives containing 4-arylthiazoles and d-glucose moiety: design, synthesis, antimicrobial activity evaluation, and molecular docking/dynamics simulations
Dunstan et al. Dipolar cycloaddition reactions of nitrilimines
KR20060043746A (ko) 중앙 디술판 연결을 갖는 전하 수송 물질
Hassan et al. Reactions of dimethyl ethynedicarboxylate with (substituted ethylidene) hydrazinecarbothioamides
MX2021014389A (es) Acero inoxidable duplex y metodo para fabricar el mismo, y tuberia de acero inoxidable duplex.
Hassan et al. The Behavior of (cyclic‐alkylidene) hydrazinecarbothioamides in Cyclization with Dimethyl acetylenedicarboxylate
Al-Khamees Synthesis of new derivatives of 1, 3, 5-Hexahydro-s-triazine as potential anticancer agents
US7169521B2 (en) Hydrazone-based charge transport materials
Meadows et al. 1-and 2-Naphthylmethyl sidearms of isomeric bibracchial lariat ethers significantly affect alkali metal cation complexation
US109895A (en) Improvement in medical compounds
US7326506B2 (en) Bridged charge transport materials having a central sulfur atom linkage
DeKorver Palladium-catalyzed and thermal rearrangements of N-allyl ynamides
Hassan et al. Reactivity of N-substituted alkenylidene hydrazinecarbothioamides toward tetracyanoethylene, an efficient synthesis stereoselective 1, 3-thiazole compounds: AA Hassan et al.